Correlation Between Mink Therapeutics and Maplebear Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Maplebear Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Maplebear Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Maplebear Common Stock, you can compare the effects of market volatilities on Mink Therapeutics and Maplebear Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Maplebear Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Maplebear Common.

Diversification Opportunities for Mink Therapeutics and Maplebear Common

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Mink and Maplebear is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Maplebear Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maplebear Common Stock and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Maplebear Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maplebear Common Stock has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Maplebear Common go up and down completely randomly.

Pair Corralation between Mink Therapeutics and Maplebear Common

Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Maplebear Common. In addition to that, Mink Therapeutics is 1.32 times more volatile than Maplebear Common Stock. It trades about -0.08 of its total potential returns per unit of risk. Maplebear Common Stock is currently generating about 0.09 per unit of volatility. If you would invest  3,324  in Maplebear Common Stock on September 14, 2024 and sell it today you would earn a total of  854.00  from holding Maplebear Common Stock or generate 25.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Mink Therapeutics  vs.  Maplebear Common Stock

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Maplebear Common Stock 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Maplebear Common Stock are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Maplebear Common may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Mink Therapeutics and Maplebear Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and Maplebear Common

The main advantage of trading using opposite Mink Therapeutics and Maplebear Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Maplebear Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maplebear Common will offset losses from the drop in Maplebear Common's long position.
The idea behind Mink Therapeutics and Maplebear Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities